Humanoid robots recently scrubbed in at UC San Diego and successfully removed gallbladders from live pigs, marking a world‑first teleoperated surgical milestone that investors in robotics, AI, and med‑tech will want on their radar.
When Wall Street Meets the Operating Room
For…
The FT film argues that India’s tech model is being rewired by AI, with data annotation, robot training, and global capability centers replacing the old back-office script, while Indian IT services still carry major export weight and now face both risk and…
Wall Street is treating artificial intelligence less like a bubble and more like a new asset class, and the early winners—from SoftBank to NVIDIA to Apple to IBM—are already writing the opening chapter of what looks increasingly like a durable profit supercycle.
The Gospel According to Masayoshi Son
In…
A San Diego upstart armed with FDA clearance, first commercial shipments, and an audacious two-part pump design is stepping into a multi-billion-dollar market that the industry's giants have repeatedly fumbled
The Patient Nobody Wanted to Build For
For decades, the diabetes device…
U.S. stocks traded with a cautious, slightly risk‑off tone on Monday, July 13, 2026, as investors weighed Middle East tensions, upcoming earnings, and the next batch of inflation data, while select healthcare, industrial, and media names saw idiosyncratic moves.
Market overview…
Agenus Inc. (NASDAQ: AGEN) and Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX, TSX: EPRX) just offered Wall Street a reminder that in biotech, capital and human capital still set the tempo—one via an oversubscribed private placement, the other via a board refresh that reads…
AI isn’t just knocking on the data center door anymore; it is wiring the building, staffing the call center, and quietly re‑pricing entire sectors for investors. From Meta Platforms (NASDAQ: META) in Louisiana to Doximity (NYSE: DOCS), Amwell (NYSE: AMWL), Similarweb (NYSE:…
Trump’s policy muse, Amwell’s telehealth pivot, and Modular Medical’s insulin innovation together sketch a quietly bullish narrative for investors betting on healthcare, retirement and digital infrastructure in the Trump economy.
Retirement Goes Down Under, Markets Look Up
President Donald Trump’s latest policy…
Beef is getting pricier just as biotech is getting hotter, and for investors willing to look past the grocery aisle to the lab bench, that may be the more interesting inflation story.
From Ribeye Shock to Risk-On: The Macro Backdrop
Consumers may…
U.S. equities finished the week ending Friday, July 10, 2026 on a constructive note, with growth and AI‑linked names back in favor even as oil and geopolitical risks kept macro uncertainty elevated.
Equity markets: AI leadership, broader participation
The S&P 500 Index…
